In the case of a severe allergic reaction, study results showed that epinephrine delivered via the nose had a similar influence on heart rate and blood pressure as an injection. Maskot/Getty Images
Anaphylaxis, a severe allergic reaction, is often treated using epinephrine.
Epinephrine is administered via injection through devices such as EpiPens.
But soon people may have the option to use a nasal spray instead.
Studies indicate the nasal spray may be as effective in treating anaphylaxis as an injection.
Anaphylaxis — a potentially life-threatening allergic reaction — is common in the US. It’s estimated that up to 5%Trusted Source of people have experienced anaphylaxis.
It is vital to treat severe allergic reactions as quickly as possible and the current treatment involves using a needle-based device like an EpiPen to get an injection of epinephrine.
However, a potential new nasal spray device, known as “Neffy,” could soon be used to deliver epinephrine.
An external advisory committee to the Food and Drug Administration (FDA) recently voted in support of the product.
In a statement, ARS Pharmaceuticals, the makers of Neffy, said a final FDA decision is expected by mid-2023.
Leave a Reply